Cancer Letters
Volume 294, Issue 2 , Pages 245-253, 28 August 2010

A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro

  • Eri Kawata

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • Division of Internal Medicine, Kyoto Second Red Cross Hospital, 355 Kamannza Marutamachi, Kamigyo-ku, Kyoto 602-8026, Japan
    • These authors contribute equal to this work.
    • ,
  • Eishi Ashihara

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 75 751 3630; fax: +81 75 751 4283.
    • These authors contribute equal to this work.
    • ,
  • Yoko Nakagawa

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Takahiro Kiuchi

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Mai Ogura

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Hisayuku Yao

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Kazuki Sakai

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Ruriko Tanaka

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Rina Nagao

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Asumi Yokota

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Miki Takeuchi

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Shinya Kimura

      Affiliations

    • Division of Hematology, Respiratory Medicine, and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan
    • ,
  • Hideyo Hirai

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Taira Maekawa

      Affiliations

    • Department of Transfusion Medicine & Cell Therapy, Kyoto University Hospital, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

Received 24 November 2009; received in revised form 6 February 2010; accepted 10 February 2010. published online 08 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3835(10)00096-0

doi:10.1016/j.canlet.2010.02.008

Cancer Letters
Volume 294, Issue 2 , Pages 245-253, 28 August 2010

Article Tools

* Image Usage & Resolution